Share on LinkedInShare on LinkedIn

ARTICLE · 28 NOVEMBER 2025

Market Intelligence Thought Leadership Award Winner

Confidentiality In Clinical Trials: Arbitration As The Preferred Route For Dispute Resolution

Browne Jacobson LLP
Browne Jacobson LLP
Contributor
Browne Jacobson LLP

Browne Jacobson LLP

We’re Browne Jacobson. The law firm for positive impact across business and society. Social and...

View firm profile
Explore more from Browne Jacobson LLP

In the life sciences sector, clinical trials are the engine of innovation but also a source of risk.

United KingdomLitigation, Mediation & Arbitration

In the life sciences sector, clinical trials are the engine of innovation but also a source of risk. Disputes over trial outcomes, safety protocols, or licensing terms can derail product pipelines and irreversibly damage reputations.

Arbitration offers a private, flexible, and procedurally dynamic forum to resolve these conflicts without exposing sensitive data or commercial strategies.

The legal framework: Arbitral confidentiality under English law

Unlike English court proceedings, which are underpinned by principals of open justice and therefore generally open to the public, English law arbitration is a private process. The default rule under English law is that arbitral proceedings in England are subject to an implied duty of confidentiality.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from